Leukemia and Lymphoma Society Summarizes Major Advances in Treatment of Blood Cancers Presented at American Society of Hematology Meetings – CancerConnect News : CancerConnect News


Clinical findings presented at the 57th American Society of Hematology (ASH) Annual Meeting, in Orlando, December 5-8, made it increasingly clear that new discoveries in precision medicine and immunotherapy are leading to breakthrough therapies for a wide array of blood patients. As the world’s leading voluntary non-profit dedicated to finding cures and ensuring that patients with leukemia, lymphoma, myeloma, and other blood cancers have access to lifesaving treatments and cures, LLS has been funding many of the leading researchers who presented their work in targeting genetic and molecular mutations and effectively harnessing the body’s immune system to fight cancer.


CAR-T Chimeric antigen receptor (CAR) T-cell immunotherapy, in which immune system T-cells are removed from the patient’s body and reprogrammed to find and attach the tumor cells continues to show promise. LLS funds CAR-T programs at a number of institutions and is dedicated to a comprehensive CAR-T education program as well.


Three new therapies to treat patients with multiple myeloma were FDA approved in just the past two weeks and were a focus during ASH. LLS-supported work in myeloma was also featured, including:


“The promising research presented at ASH, including significant advances funded by LLS, demonstrates that we are at a momentous time in the treatment of blood cancers,” said LLS President and CEO Louis J. DeGennaro, Ph.D. “Every day, scientists are uncovering the mysteries of why cancers occur, leading to more precise and novel new treatments for patients. LLS’s investment of more than $1 billion in research to advance lifesaving treatments is playing a critical role in these advances, making someday today for more patients.”


For the more than one million Americans living with or in remission from a blood cancer, there is more hope than ever for new treatments and even cures—not someday, but today.



Check Also

‘Suicide’ gene therapy kills prostate cancer cells – BBC News

Using a virus to carry the gene therapy into the tumour cells, the result is ...

Leave a Reply

Your email address will not be published. Required fields are marked *